Trials / Conditions / Liver Transplant Rejection

Liver Transplant Rejection

20 registered clinical trials studyying Liver Transplant Rejection — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection NCT07053488	AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC	Phase 1 / Phase 2
Recruiting	Safety of DNP007 in Healthy Subjects NCT06400771	Seoul National University Hospital	Phase 1
Enrolling By Invitation	Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients NCT05655273	University Health Network, Toronto	Phase 4
Unknown	Long-term Benefit of MPA in Liver Transplantation NCT05707520	Third Affiliated Hospital, Sun Yat-Sen University	—
Unknown	TRU-IMMUNO: Optimizing Liver Immunosuppression NCT05335551	Transplant Genomics, Inc.	—
Enrolling By Invitation	Global Utilization And Registry Database for Improved preservAtion of doNor Livers NCT05082077	Paragonix Technologies	—
Active Not Recruiting	Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients NCT05325073	Northwestern University	Phase 4
Unknown	VOCs in Kidney and Liver Transplants NCT04514666	Societa Italiana di Chirurgia ColoRettale	N/A
Completed	Role of NFKBIA and PTPN22 Genes Polymorphism in Acute Rejection Susceptibility After Living Donor Liver Transp NCT06060808	Helwan University	—
Completed	Mortality, Morbidity and Risk Factors of Liver Retransplantation NCT04789213	Memorial Bahçelievler Hospital	—
Unknown	The New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma NCT04657562	National Science Centre, Poland	—
Terminated	Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclo NCT03781414	Novartis Pharmaceuticals	Phase 2
Active Not Recruiting	Cytokeratin 18 Non-invasive Biomarker for Rejection in Liver Transplant Patients NCT06153641	St. Louis University	—
Withdrawn	Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects NCT03315052	Montefiore Medical Center	Phase 4
Unknown	Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) NCT03603548	Medical University of Warsaw	N/A
Completed	The TOGETHER Project - Liver NCT03874286	Mayo Clinic	—
Unknown	MSC Therapy in Liver Transplantation NCT02260375	Monia Lorini	Phase 1
Completed	Graft Rejection or Tolerance Affected by Serial Change of Anti-donor Lymphocyte Antibody After Liver Transplan NCT01444079	Yonsei University	—
Completed	Cell Infusion Intraportal Autologous Bone Marrow Mononuclear as Enhancer of Liver Regeneration NCT01745731	Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud	Phase 2
Completed	Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive NCT01678937	Northwestern University	—